Freezing away heart flutter: new device tested in valve surgery patients

NCT ID NCT06557616

First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 31 times

Summary

This study tests a new device called CoolCryo that uses freezing (cryoablation) to treat atrial fibrillation, an irregular heartbeat, in people who are already having mitral valve surgery. About 20 adults with atrial fibrillation for at least 3 months will receive the freezing treatment during their surgery. The main goals are to see if the device safely stops the irregular heartbeat for at least 6 months and to track any side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITRAL VALVE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Antoni Jurasz University Hospital No. 1

    RECRUITING

    Bydgoszcz, 85-094, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Silesian Centre for Heart Diseases

    RECRUITING

    Zabrze, 41-800, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.